Shareholding disclosure

Martin und Rosmarie Ebner

Declared position

18.11%

Threshold

Crossed upwards

Timeline

Published

23.01.2016

Transaction

21.01.2016

Voting rights breakdown

Voting rights acquired18.11%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAG1M000B4

Beneficial owner

Martin und Rosmarie Ebner

Declared address

Martin und Rosmarie Ebner, 8832 Wilen

Zusätzliche direkt Beteiligte

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Martin und Rosmarie Ebner

Vifor Pharma AG23.01.2016TAG1M000B4

Disclosure summary

Martin und Rosmarie Ebner disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 23.01.2016, at 18.11% of voting rights. Notice category: Single shareholder.

Disclosed position

18.11%

Voting rights acquired

Voting rights acquired18.11%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Martin und Rosmarie Ebner disclosed a holding in Vifor Pharma AG, published on 23.01.2016.

Publication date23.01.2016

Transaction date21.01.2016

Issuing companyVifor Pharma AG

Beneficial ownerMartin und Rosmarie Ebner

Declared addressMartin und Rosmarie Ebner, 8832 Wilen

CategorySingle shareholder

Voting rights acquired18.11%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAG1M000B4

Conditions

Zusätzliche direkt Beteiligte

Source: SIX Exchange Regulation · Publication date: 23.01.2016

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open